Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Common Stock 0.001 Par Value
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interest
Balance, beginning balance at Dec. 31, 2018 $ 28,037,774 $ 24,825 $ 56,427,928 $ (28,670,095) $ 255,116
Beginning balance, shares at Dec. 31, 2018   24,824,746      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options 33,617 $ 24 33,593    
Stock issuance costs (2,700)   (2,700)    
Exercise of stock options, shares   24,515      
Distributions to non-controlling interest (84,505)       (84,505)
Stock-based compensation 163,464   163,464    
Net loss (4,709,019)     (4,709,019)  
Net loss 85,354       (85,354)
Net loss (4,794,373)        
Balance, ending balance at Dec. 31, 2019 $ 23,353,277 $ 24,849 56,622,285 (33,379,114) 85,257
Ending balance, shares at Dec. 31, 2019   24,849,261      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock, par value (usd per share) $ 0.001        
Exercise of stock options $ 1,200 $ 1 1,199    
Exercise of stock options, shares   1,000      
Distributions to non-controlling interest (60,896)       (60,896)
Stock-based compensation 190,944   190,944    
Net loss (6,150,507)     (6,150,507)  
Net loss 66,684       (66,684)
Net loss (6,217,191)        
Balance, ending balance at Dec. 31, 2020 $ 17,267,334 $ 24,850 $ 56,814,428 $ (39,529,621) $ (42,323)
Ending balance, shares at Dec. 31, 2020   24,850,261      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock, par value (usd per share) $ 0.001